Vanda Pharmaceuticals (VNDA) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

VNDA is expected to report earnings to rise 112.50% to -17 cents per share on October 30

Vanda Pharmaceuticals VNDA Stock Earnings Reports

Q3'24

Est.

$-0.17

Q2'24

Beat

by $0.05

Q1'24

Missed

by $0.12

Q4'23

Beat

by $0.05

Q3'23

Beat

by $0.04

The last earnings report on July 31 showed earnings per share of -7 cents, beating the estimate of -12 cents. With 442.54K shares outstanding, the current market capitalization sits at 272.21M.

View a ticker or compare two or three

Compare

VNDA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VNDA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for VNDA (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a manufacturer of biopharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2200 Pennsylvania Avenue NW

Phone

+1 202 734-3400

Employees

203

Web

https://www.vandapharma.com